Logo image of NDX1.DE

NORDEX SE (NDX1.DE) Stock Fundamental Analysis

FRA:NDX1 - Deutsche Boerse Ag - DE000A0D6554 - Common Stock - Currency: EUR

17.93  -0.35 (-1.91%)

Fundamental Rating

4

Taking everything into account, NDX1 scores 4 out of 10 in our fundamental rating. NDX1 was compared to 959 industry peers in the Electrical Equipment industry. NDX1 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NDX1 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

NDX1 had positive earnings in the past year.
NDX1 had a positive operating cash flow in the past year.
In the past 5 years NDX1 reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: NDX1 reported negative operating cash flow in multiple years.
NDX1.DE Yearly Net Income VS EBIT VS OCF VS FCFNDX1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

NDX1 has a Return On Assets (0.53%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 3.02%, NDX1 is in line with its industry, outperforming 53.70% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.75%, NDX1 is in line with its industry, outperforming 51.85% of the companies in the same industry.
Industry RankSector Rank
ROA 0.53%
ROE 3.02%
ROIC 3.75%
ROA(3y)-5.3%
ROA(5y)-4.89%
ROE(3y)-28.94%
ROE(5y)-25.05%
ROIC(3y)N/A
ROIC(5y)N/A
NDX1.DE Yearly ROA, ROE, ROICNDX1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

NDX1's Profit Margin of 0.42% is in line compared to the rest of the industry. NDX1 outperforms 50.00% of its industry peers.
NDX1's Operating Margin of 2.61% is in line compared to the rest of the industry. NDX1 outperforms 48.15% of its industry peers.
In the last couple of years the Operating Margin of NDX1 has grown nicely.
NDX1's Gross Margin of 12.03% is on the low side compared to the rest of the industry. NDX1 is outperformed by 87.04% of its industry peers.
In the last couple of years the Gross Margin of NDX1 has declined.
Industry RankSector Rank
OM 2.61%
PM (TTM) 0.42%
GM 12.03%
OM growth 3YN/A
OM growth 5Y57.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.47%
GM growth 5Y-2.61%
NDX1.DE Yearly Profit, Operating, Gross MarginsNDX1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NDX1 is destroying value.
Compared to 1 year ago, NDX1 has about the same amount of shares outstanding.
The number of shares outstanding for NDX1 has been increased compared to 5 years ago.
NDX1 has a worse debt/assets ratio than last year.
NDX1.DE Yearly Shares OutstandingNDX1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NDX1.DE Yearly Total Debt VS Total AssetsNDX1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

NDX1 has an Altman-Z score of 1.89. This is not the best score and indicates that NDX1 is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.89, NDX1 is in line with its industry, outperforming 57.41% of the companies in the same industry.
There is no outstanding debt for NDX1. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.09
Altman-Z 1.89
ROIC/WACC0.45
WACC8.25%
NDX1.DE Yearly LT Debt VS Equity VS FCFNDX1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

NDX1 has a Current Ratio of 1.00. This is a normal value and indicates that NDX1 is financially healthy and should not expect problems in meeting its short term obligations.
NDX1 has a Current ratio of 1.00. This is amonst the worse of the industry: NDX1 underperforms 85.19% of its industry peers.
NDX1 has a Quick Ratio of 1.00. This is a bad value and indicates that NDX1 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.73, NDX1 is not doing good in the industry: 74.07% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.73
NDX1.DE Yearly Current Assets VS Current LiabilitesNDX1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

NDX1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 134.21%, which is quite impressive.
Looking at the last year, NDX1 shows a small growth in Revenue. The Revenue has grown by 4.58% in the last year.
NDX1 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.32% yearly.
EPS 1Y (TTM)134.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y10.27%
Revenue growth 5Y17.32%
Sales Q2Q%-8.83%

3.2 Future

Based on estimates for the next years, NDX1 will show a very strong growth in Earnings Per Share. The EPS will grow by 148.10% on average per year.
NDX1 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.21% yearly.
EPS Next Y1641.27%
EPS Next 2Y397.7%
EPS Next 3Y212.24%
EPS Next 5Y148.1%
Revenue Next Year5.07%
Revenue Next 2Y5.55%
Revenue Next 3Y5.25%
Revenue Next 5Y2.21%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NDX1.DE Yearly Revenue VS EstimatesNDX1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
NDX1.DE Yearly EPS VS EstimatesNDX1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 137.92, which means the current valuation is very expensive for NDX1.
Based on the Price/Earnings ratio, NDX1 is valued a bit cheaper than 61.11% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.52. NDX1 is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 18.10, which indicates a rather expensive current valuation of NDX1.
The rest of the industry has a similar Price/Forward Earnings ratio as NDX1.
NDX1's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.25.
Industry RankSector Rank
PE 137.92
Fwd PE 18.1
NDX1.DE Price Earnings VS Forward Price EarningsNDX1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NDX1 is valued a bit cheaper than 72.22% of the companies in the same industry.
88.89% of the companies in the same industry are more expensive than NDX1, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.43
EV/EBITDA 8.27
NDX1.DE Per share dataNDX1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

NDX1's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NDX1's earnings are expected to grow with 212.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y397.7%
EPS Next 3Y212.24%

0

5. Dividend

5.1 Amount

NDX1 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NORDEX SE

FRA:NDX1 (6/6/2025, 7:00:00 PM)

17.93

-0.35 (-1.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)04-25 2025-04-25/bmo
Earnings (Next)07-28 2025-07-28
Inst Owners36.05%
Inst Owner ChangeN/A
Ins Owners2.96%
Ins Owner ChangeN/A
Market Cap4.24B
Analysts85.71
Price Target19.14 (6.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.51%
Min EPS beat(2)-48.1%
Max EPS beat(2)65.12%
EPS beat(4)2
Avg EPS beat(4)10.22%
Min EPS beat(4)-86.48%
Max EPS beat(4)110.32%
EPS beat(8)4
Avg EPS beat(8)16.99%
EPS beat(12)5
Avg EPS beat(12)-6.5%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.62%
Min Revenue beat(2)-14.66%
Max Revenue beat(2)-14.57%
Revenue beat(4)1
Avg Revenue beat(4)-8.94%
Min Revenue beat(4)-15.62%
Max Revenue beat(4)9.08%
Revenue beat(8)5
Avg Revenue beat(8)1.47%
Revenue beat(12)8
Avg Revenue beat(12)3.48%
Revenue beat(16)10
Avg Revenue beat(16)2.63%
PT rev (1m)1.3%
PT rev (3m)10.91%
EPS NQ rev (1m)-8%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)8.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.36%
Valuation
Industry RankSector Rank
PE 137.92
Fwd PE 18.1
P/S 0.59
P/FCF 8.43
P/OCF 6.44
P/B 4.29
P/tB 17.69
EV/EBITDA 8.27
EPS(TTM)0.13
EY0.73%
EPS(NY)0.99
Fwd EY5.53%
FCF(TTM)2.13
FCFY11.87%
OCF(TTM)2.78
OCFY15.52%
SpS30.28
BVpS4.18
TBVpS1.01
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.53%
ROE 3.02%
ROCE 9.19%
ROIC 3.75%
ROICexc 9.48%
ROICexgc 134.83%
OM 2.61%
PM (TTM) 0.42%
GM 12.03%
FCFM 7.03%
ROA(3y)-5.3%
ROA(5y)-4.89%
ROE(3y)-28.94%
ROE(5y)-25.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y149.59%
ROICexc growth 3YN/A
ROICexc growth 5Y97.25%
OM growth 3YN/A
OM growth 5Y57.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.47%
GM growth 5Y-2.61%
F-Score7
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.09
Debt/EBITDA 0
Cap/Depr 85.98%
Cap/Sales 2.16%
Interest Coverage 1.76
Cash Conversion 179.18%
Profit Quality 1687.69%
Current Ratio 1
Quick Ratio 0.73
Altman-Z 1.89
F-Score7
WACC8.25%
ROIC/WACC0.45
Cap/Depr(3y)91.26%
Cap/Depr(5y)96.94%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)134.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y1641.27%
EPS Next 2Y397.7%
EPS Next 3Y212.24%
EPS Next 5Y148.1%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y10.27%
Revenue growth 5Y17.32%
Sales Q2Q%-8.83%
Revenue Next Year5.07%
Revenue Next 2Y5.55%
Revenue Next 3Y5.25%
Revenue Next 5Y2.21%
EBIT growth 1Y62.39%
EBIT growth 3YN/A
EBIT growth 5Y85.18%
EBIT Next Year411.26%
EBIT Next 3Y90.65%
EBIT Next 5Y45.2%
FCF growth 1Y195.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y290.87%
OCF growth 3Y49.91%
OCF growth 5Y62.45%